Nasdaq: FENC

Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker FENC. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
FENC
Exchange
Nasdaq
SEC CIK
1211583
Official filings
SEC EDGAR

Research FENC

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Fennec Pharmaceuticals Inc.'s stock ticker?

Fennec Pharmaceuticals Inc. trades under the ticker symbol FENC on Nasdaq. Its SEC Central Index Key (CIK) is 1211583.

Where can I read Fennec Pharmaceuticals Inc.'s SEC filings?

The FENC SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Fennec Pharmaceuticals Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze FENC's financial statements?

The FENC Financials page shows Fennec Pharmaceuticals Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does FENC compare with its peers and the market?

The FENC Peer Comparison page lines Fennec Pharmaceuticals Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.